Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Gains from Investment Securities (2020 - 2024)

Immuneering has reported Gains from Investment Securities over the past 5 years, most recently at -$5469.0 for Q4 2024.

  • Quarterly results put Gains from Investment Securities at -$5469.0 for Q4 2024, down 122.68% from a year ago — trailing twelve months through Dec 2024 was -$6784.0 (down 72.23% YoY), and the annual figure for FY2025 was -$2093.0, up 69.15%.
  • Gains from Investment Securities for Q4 2024 was -$5469.0 at Immuneering, down from -$1315.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for IMRX hit a ceiling of $3.7 million in Q1 2022 and a floor of -$5469.0 in Q4 2024.
  • Median Gains from Investment Securities over the past 5 years was $276795.0 (2022), compared with a mean of $790255.1.
  • Biggest five-year swings in Gains from Investment Securities: surged 833.83% in 2021 and later plummeted 122.68% in 2024.
  • Immuneering's Gains from Investment Securities stood at $343169.0 in 2020, then soared by 323.25% to $1.5 million in 2021, then tumbled by 100.36% to -$5170.0 in 2022, then skyrocketed by 52.5% to -$2456.0 in 2023, then tumbled by 122.68% to -$5469.0 in 2024.
  • The last three reported values for Gains from Investment Securities were -$5469.0 (Q4 2024), -$1315.0 (Q3 2024), and -$2456.0 (Q4 2023) per Business Quant data.